The bill enacts a new section of the New Mexico Insurance Code that prohibits discrimination against entities participating in the federal 340B Drug Pricing Program. It defines key terms such as "340B drug," "340B program," "affiliate," "covered entity," and "manufacturer." The legislation aims to protect covered entities and their contracted pharmacies from actions by manufacturers or their affiliates that could hinder their ability to acquire or dispense 340B drugs.

Specifically, the bill prohibits manufacturers, their agents, or affiliates from denying, restricting, or interfering with the acquisition or delivery of 340B drugs to pharmacies under contract with covered entities. Additionally, it prevents these parties from interfering with contracted pharmacies or requiring covered entities to submit claims or utilization data as a condition for acquiring 340B drugs, unless mandated by federal law. This legislation seeks to ensure that covered entities can effectively participate in the 340B program without facing undue barriers.